8 source-based articles maintained by the HealthRX.com Editorial Team.
Showing 8 of 8 clinical reviews.
A complete guide to metformin's FDA approval history, compounding legal status, label requirements, and post-market safety record. prepared by the HealthRX.com Editorial Team.
A side-by-side comparison of how the FDA and EMA regulate metformin, including approval history, label differences, renal thresholds, safety monitoring, and post-market surveillance.
A clinical review of metformin safety signals in the FDA Adverse Event Reporting System (FAERS), including lactic acidosis, B12 deficiency, NDMA contamination, and updated renal dosing guidance.
A complete timeline of metformin's FDA approval, label expansions, safety reviews, and regulatory milestones from 1994 to the present day.
A complete overview of metformin's regulatory history across the FDA, EMA, and other global agencies, including approval timelines, labeling updates, NDMA concerns, and current prescribing status.
The FDA metformin label recommends measuring vitamin B12 at baseline and periodically, typically every 1 to 2 years, especially with anemia or neuropathy.
A complete guide to metformin's regulatory history, patent expiration, FDA label updates, NDMA contamination actions, and ongoing post-market safety surveillance, prepared by the HealthRX.com Editorial Team.
A comprehensive look at metformin's FDA approval history, current label requirements, post-market surveillance findings, and what next-generation biguanide-class research means for clinical practice.